Abstract: Disclosed are peptides comprising a p53 peptide and a BH3-only protein. In some aspects, wherein the BH3-only protein is BAD, BID, BIM, NOXA. Disclosed are nucleic acid sequences comprising a sequence capable of encoding a p53 peptide operably linked to a nucleic acid sequence capable of encoding a BH3-only protein. Disclosed are nucleic acid sequences comprising a sequence capable of encoding one or more of the peptides disclosed herein. Disclosed are vectors comprising a nucleic acid sequence, wherein the nucleic acid sequence is capable of encoding one or more of the peptides disclosed herein. Also disclosed are methods of using the disclosed peptides, nucleic acid sequences, and vectors.

Abstract: In one aspect, the invention relates to compositions comprising stapled peptides, methods of making same, pharmaceutical compositions comprising same, and methods of treating various diseases, including, but not limited to, metabolic disorders such as diabetes, and cancers. The disclosed compounds comprise stapled peptides, including, but not limited to, stapled glucagon, axin, and p53 peptide homologues, which are useful as therapeutic agents for a variety of diseases as disclosed herein. The disclosed methods are useful in the preparation of a variety of stapled peptides, including stapled peptide homologues of glucagon, axin, and p53. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Abstract: A cathode (100) for use in a lithium-air battery can include a polymer binder (150) having a conductive material (120), phyllosilicate nanoparticles (110), a lithium salt (130), and a metal catalyst (140) distributed in the polymer binder (150). The cathode (100) can be porous to allow oxygen to diffuse from surrounding air into the cathode (100). A lithium-air battery can include a lithium metal anode, a solid electrolyte in contact with the lithium metal anode, and a cathode (100) in contact with the solid electrolyte. The cathode (100) can have a polymer binder (150) as a support matrix. The polymer binder (150) can be porous to allow oxygen to diffuse from surrounding air into the cathode (100). The cathode (100) can include the polymer binder (150), a conductive material (120), phyllosilicate nanoparticles (110), a lithium salt (130), and a metal catalyst (140) distributed in the polymer binder (150).

Abstract: Methods, devices, and kits are provided for performing PCR and other thermal cycling reactions in <20 seconds per cycle, using induction heating.

Abstract: The application discloses multimeric assemblies including multiple oligomeric substructures, where each oligomeric substructure includes multiple proteins that self-interact around at least one axis of rotational symmetry, where each protein includes one or more polypeptide-polypeptide interface (“O interface”); and one or more polypeptide domain that is capable of effecting membrane scission and release of an enveloped multimeric assembly from a cell by recruiting the ESCRT machinery to the site of budding by binding to one or more proteins in the eukaryotic ESCRT complex (“L domain”); and where the multimeric assembly includes one or more subunits comprising one or more polypeptide domain that is capable of interacting with a lipid bilayer (“M domain”), as well as membrane-enveloped versions of the multimeric assemblies.

Abstract: Disclosed herein are compositions and methods for inhibiting viral entry.

Abstract: Methods, devices, and kits are provided for performing PCR in <20 seconds per cycle, with improved efficiency and yield.

Abstract: Devices, systems, and methods for measuring the blood loss of a subject during a medical procedure. Blood and other fluids are received within a container, and a blood measurement device determines the hemoglobin concentration of the fluid within the container. The blood measurement device can also calculate the estimated blood loss of the subject based upon the determined hemoglobin concentration and the volume of the fluid within the container and the patient's hemoglobin.

Abstract: A chemiresistive vapor sensor compound for detecting target vapors can comprise a perylene-tetracarboxylic diimide (PTCDI) core according to structure (I): where R can be a morphology control group or -A?-D?, A and A? can be independently a linking group, D and D? can be independently a strong electron donor which transfers electrons to the PTCDI core sufficient to form an anionic PTCDI radical of the PTCDI core, and R1 to R8 can be independently a side group. A chemiresistive vapor sensor for detection of a target compound can comprise an assembly of nanofibers formed of the chemiresistive sensor compound and a pair of electrodes operatively oriented about the assembly of nanofibers to allow electrical current to pass from a first electrode in the pair of electrodes through the assembly of nanofibers and to a second electrode in the pair of electrodes.

Abstract: Devices, systems, and methods for determining a distance between at least two points are disclosed and described, wherein interferometry technology is utilized to determine such distances.

Abstract: A field effect transistor (FET) biosensor for virus detection of a selected virus within a sample volume is disclosed. The FET comprises a semiconductor substrate, a source and drain electrode on the substrate, the electrodes spaced to form a channel. A gate electrode carried on the substrate and located in the channel between the source and drain electrodes. An insulating layer is coupled to a top surface of the gate electrode and a bottom surface of the source and drain electrodes, with an open channel above the insulating layer. A channel material is coupled to the insulating layer. Aptamers are oriented within the open channel to bind to the channel material and with the selected virus to enable a detection of the selected virus by the FET biosensor based on a change in drain-source current at a selected gate voltage.

Abstract: An MRI system uses a Cartesian-radial hybrid k-space trajectory to capture three-dimensional k-space data and reconstruct an image of an area of interest of a subject. The MRI system performs a series of k-space acquisitions to collect the data. A first k-space acquisition includes acquiring a two-dimensional EPI projection in a first plane parallel to a frequency-encoding direction and acquiring additional two-dimensional EPI projections in planes that are radially shifted about a center axis parallel to the frequency-encoding direction with respect to the first plane, until a selected number of projections are acquired. Each subsequent k-space acquisition includes acquiring an additional set of two-dimensional EPI projections in all of the planes in which an EPI projection was acquired during the first k-space acquisition, each additional set of EPI projections being shifted along a respective plane in a direction perpendicular to the frequency-encoding direction.

Abstract: A thermoelectric material, having a formula TbxM1y-xM2zOw where M1 is one of Ca, Mg, Sr, Ba and Ra, M2 is at least one of Co, Fe, Ni, and Mn, x ranges from 0.01 to 5; y is 1, 2, 3, or 5; z is 1, 2, 3, or 4; and w is 1, 2, 3, 4, 5, 7, 8, 9, or 14. The thermoelectric material is chemically stable within 5% for one year and is also non-toxic. The thermoelectric material can also be incorporated into a thermoelectric system which can be used to generate electricity from waste heat sources or to cool an adjacent region.

Abstract: Chemical probes and methods for detecting and/or quantifying hydrogen sulfide are disclosed. More particularly, this application discloses chemical probes and methods for their use for detecting and/or quantifying hydrogen sulfide in industrial and environmental samples and effluents, including samples of crude oil and sour water produced by petrochemical and other industrial processes.

Abstract: Ultra-high b radial diffusion-weighted imaging signals can be obtained from a selected portion of a nervous system of a subject. At least two ultra-high b radial diffusion-weighted imaging signals for the selected portion of the nervous system of the subject can be compared. The comparison is indicative of changes in the integrity or intactness of a bundle of axons within the selected portion of the nervous system of the subject.

Abstract: Embodiments of the disclosure are drawn to apparatuses and methods for a tunable digital power amplifier (DPA). The tunable DPA may be coupled to a reconfigurable capacitor to form a frequency tunable DPA. The capacitance of the reconfigurable capacitor may be adjusted to optimize the DPA to operate at a desired frequency band. The single tunable DPA may operate over a wide range of frequencies.

Abstract: Disclosed are peptide conjugates comprising an active agent, a spacer moiety, and a dimeric collagen hybridizing peptide comprising a first and second collagen hybridizing peptide, a linker; and a branch point, wherein the first and second collagen hybridizing peptides comprise the sequence of at least (GXY)n, wherein G is glycine, wherein X and Y are any amino acid, and wherein n is any number between 3 and 12. Also disclosed are methods of detecting denatured collagen in a sample comprising contacting a composition comprising any one of the disclosed peptide conjugates to a sample, wherein the active agent comprises a therapeutic agent, and detecting the presence or absence of binding of the peptide conjugate to denatured collagen, the presence of binding indicating the presence of denatured collagen in the sample.

Abstract: Described herein are compositions and methods for treatment and prevention of low back pain. The compositions include vectors comprising nucleotide sequences encoding one or more CRISPR-Cas system guide RNAs and a RNA-directed nuclease. The methods include modulating expression of a gene in a cell using said compositions, introducing a CRISPR-Cas system into a cell comprising one or more vectors comprising said compositions, inducing site-specific DNA cleavage in a cell, and treating a subject having lower back pain, and lower back pain caused by degenerative disc disease using the compositions disclosed herein.

Abstract: The present invention relates to synthetic analgesic peptides that are analogs of the ?-conotoxin peptide RgIA and their use for treating pain and other disorders.

Abstract: An ophthalmic composition or dosage form can include a therapeutically effective amount of a copper-containing agent that is sufficient to increase corneal lysyl oxidase activity in an eye of a subject in an amount sufficient to treat myopic progression and a pharmaceutically acceptable carrier. The composition or dosage form can be used to treat or prevent progression of myopia by administering a therapeutically effective amount of the composition to an eye of a subject during a treatment period.